CD55 and Burkitt lymphoma: An in vivo model of Burkitt's lymphoma developed in SCID mice was used to investigate the tissue distribution of bispecific Abs that were found to target selectively the tumor mass due to the high affinity of the anti-CD20 portion as opposed to the lower affinity of the anti-CD55 or anti-CD59 arms and to prevent tumor development (60).